Jin Biotech Rises 2.68% Amid Anthelmintic (Fenbendazole, etc.) Theme Uptrend

On the 6th, the deworming drug theme (including Fenbendazole) showed strength by rising 4.00% compared to the previous day, while Jin Biotech, which is attracting attention as a related stock, surged by 2.68% compared to the previous day. Jin Biotech is known as a manufacturer of functional feed additives and veterinary pharmaceuticals.

[Graph] Major stock price changes in the deworming drug theme (including Fenbendazole)



According to the analysis by Thinkpool Robo Algorithm RASSI, Jin Biotech’s quant financial score was 28.49 points, ranking 3rd within the theme. Jin Biotech especially had a relatively high financial stability score. This indicates that Jin Biotech’s ability to respond to changes in the internal and external economic environment is better compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.